Article Information
History
- July 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nicholas C. Cullen1,†,
- Antoine Leuzy1,†,
- Sebastian Palmqvist1,10,
- Shorena Janelidze1,
- Erik Stomrud1,10,
- Pedro Pesini2,
- Leticia Sarasa2,
- José Antonio Allué2,
- Nicholas K. Proctor3,
- Henrik Zetterberg4,5,6,7,
- Jeffrey L. Dage3,
- Kaj Blennow4,5,
- Niklas Mattsson-Carlgren1,8,9,*,# and
- Oskar Hansson1,10,*,#
- 1Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden
- 2Araclon Biotech Ltd., Zaragoza, Spain
- 3Eli Lilly and Company, Indianapolis, IN, USA
- 4Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- 5Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- 6Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, United Kingdom
- 7UK Dementia Research Institute at UCL, London, United Kingdom
- 8Department of Neurology, Skåne University Hospital, Lund, Sweden
- 9Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden
- 10Memory Clinic, Skåne University Hospital, Lund, Sweden
- ↵#Correspondence and requests for materials should be addressed to
, Oskar Hansson, MD, PhD, Memory Clinic, Skåne University Hospital, SE-205 02, Malmö, Sweden, E-mail: oskar.hansson{at}med.lu.se, Tel: +46 (0)40 331 000, Or, Niklas Mattsson-Carlgren, MD, PhD, Memory Clinic, Skåne University Hospital, SE-205 02, Malmö, Sweden, E-mail: niklas.mattsson-carlgren{at}med.lu.se, Tel: +46 (0)40 331 000